Bimekizumab population pharmacokinetic and exposure-response analyses in adults with moderate to severe hidradenitis suppurativa

ACoP15 (Nov 2024), Poster: T-041

Jönsson S, Gallais F, Janssen JM, Rolleri R, Khandelwal A, Dua P, Sidhu J